San Rocco Therapeutics
San Rocco Therapeutics
Explore linked clinical trials.1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ß-Thalassemia Major With Autologous CD34+ Hematopoietic Progenitor Cells Transduced With TNS9.3.55 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene | Confirmed Diagnosis of ß-thalassemia Major | Active, not recruiting | Phase 1 | 2026-04-24 | NCT01639690 |